Novo Nordisk expects 5-9 percent sales growth in 2021

Pharmaceutical company Novo Nordisk exceeds Q4 revenue guidance and aims for a 5-9 percent increase in local currency in 2021. This would be the same level as the sales for all of 2020.
Photo: Stine Tidsvilde
Photo: Stine Tidsvilde
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

At the end of 2021 Novo Nordisk hopes to have scraped together a 5-9 percent revenue growth with a 4-8 percent higher operational result, both measured in local currency.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading